VIBERZI
· Patent Litigation & Settlement History ↓
Current GenericRadar decision
Final ANDA candidate 213522/001 on 2025-03-14. Source-level RLD/TE screen; earliest Final and exact Product source reference require independent review.
Patent estate
| Patent | Effective date | Official listing | TRUE_DS | DS grade | Claim classification / basis | PTE | PED | Family |
|---|---|---|---|---|---|---|---|---|
| 8691860 | 2028-07-07 | DS/U U-1709 | — | — | — | — | — | — |
| 9115091 | 2028-07-07 | DS/DP/U U-1738 | — | — | — | — | — | — |
| 9364489 | 2028-07-07 | U U-1709 | — | — | — | — | — | — |
| 9789125 | 2028-07-07 | DP/U U-2152 | — | — | — | — | — | — |
| 9789125 | 2028-07-07 | DP/U U-1709 | — | — | — | — | — | — |
| 7741356 | 2029-05-27 | DS/DP — | — | — | — | — | — | — |
| 10188632 | 2033-03-14 | DP — | — | — | — | — | — | — |
| 11007179 | 2033-03-14 | DP — | — | — | — | — | — | — |
| 11090291 | 2033-03-14 | DP — | — | — | — | — | — | — |
| 11160792 | 2033-03-14 | DP — | — | — | — | — | — | — |
| 11229627 | 2033-03-14 | DP — | — | — | — | — | — | — |
| 11311516 | 2033-03-14 | DP — | — | — | — | — | — | — |
| 12097187 | 2033-03-14 | U U-3475 | — | — | — | — | — | — |
| 9675587 | 2033-03-14 | DP — | — | — | — | — | — | — |
Regulatory exclusivity
| Code | Start date | End date | Scope | Entire product | All indications | Full coverage date | Combination | Source |
|---|---|---|---|---|---|---|---|---|
| No exclusivity facts are recorded in this product snapshot. | ||||||||
2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE
Generic approval evidence
| Application / product | Event | Final date | Tentative date | Applicant | Authorized generic | Exact mapping | Source |
|---|---|---|---|---|---|---|---|
| 213576 / 001 | APPLICATION_TENTATIVE_OBSERVATION · TENTATIVE_PRODUCT_SCOPE_UNVERIFIED | — | — | MSN PHARMACEUTICALS INC | N | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 213613 / 001 | APPLICATION_TENTATIVE_OBSERVATION · TENTATIVE_PRODUCT_SCOPE_UNVERIFIED | — | — | ASCEND LABORATORIES, LTD | N | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 213522 / 001 | FINAL_APPROVAL · FINAL_APPROVED | 2025-03-14 | — | ZYDUS PHARMACEUTICALS USA INC | N | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 213511 / 001 | FINAL_APPROVAL · FINAL_APPROVED | 2026-06-02 | — | AUROBINDO PHARMA LTD | N | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
Market Entry Information
API filings, authorized generics and linked regulatory milestones.
API Master Files & Certifications 0 records
Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.
| API | Holder / manufacturer | Holder country | Filing type | Number | Status | Filed date | Available for reference | Source | Last verified |
|---|---|---|---|---|---|---|---|---|---|
| No master-file or certification records are linked through public manufacturer portfolios. | |||||||||
Authorized Generics 0 records
Authorized generics are shown separately from independent ANDA approvals.
| Application / product | Applicant | Event / status | First marketed | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|
| No authorized-generic records are linked to this product. | ||||||
Tentative ANDA Approvals 0 records
Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.
| Application / product | Applicant | Event / status | Tentative date | Follow-up final approval | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|---|
| No tentative-approval records are linked to this product. | |||||||
Paragraph IV Challenges 0 records
Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.
| Application / product | Applicant | Event / status | Certification event date | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|
| No structured Paragraph IV certification events are linked in the available approval evidence. | ||||||
Final ANDA Approvals 2 records
Approval dates do not establish commercial launch. Product mapping is shown for each linked record.
| Application / product | Applicant | Event / status | Final approval date | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|
| 213522 / 001 | ZYDUS PHARMACEUTICALS USA INC | FINAL_APPROVAL · FINAL_APPROVED | 2025-03-14 | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 213511 / 001 | AUROBINDO PHARMA LTD | FINAL_APPROVAL · FINAL_APPROVED | 2026-06-02 | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
Litigation & Settlement History
Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.
No litigation or settlement record currently linked to this product.